1. 5.4 Studies on Left Ventricular Hypertrophy Regression in Arterial Hypertension: A Clear Message For The Clinician?

   • V. Giudici
   • C. Cuspidi
   • G. Mancia

   Contributions from International Congress 22 January 2013 Pages: 213 - 213

2. 5.5 Prevalence and Correlates of Multiple Organ Damage in Treated Hypertensives: Results From the ETODH Study

   • C. Cuspidi
   • C. Valerio
   • G. Mancia

   Contributions from International Congress 22 January 2013 Pages: 214 - 214

3. 5.6 The HYPERPRACT Study: a Multicentre Survey on the Accuracy of the Echocardiographic Assessment of Hypertensive Left Ventricular Hypertrophy In Clinical Practice

   • C. Cuspidi
   • M. Maisaidi
   • G. Mancia

   Contributions from International Congress 22 January 2013 Pages: 215 - 215

4. 5.7 The Input of Home Telemonitoring for the Treatment of Chronic Heart Failure in Old People at High Risk

   • M. Benvenuto
   • L. Beltrami
   • S. Carugo

   Contributions from International Congress 22 January 2013 Pages: 216 - 216

5. 5.8 Aspects of Post-Exercise Recovery in Young Hypertensives Borderline

   • G. Ratti
   • C. Elettrico
   • P. Capogrosso

   Contributions from International Congress 22 January 2013 Pages: 217 - 217

6. 5.9 Left Ventricular Asymmetry in Hypertension: Effects on the QT Dispersion

   • G. Ratti
   • F. Buono
   • P. Capogrosso

   Contributions from International Congress 22 January 2013 Pages: 217 - 217

7. 5.10 Paracetamol Increases 24-Hour Blood Pressure and Heart Rate in Patients with Stable Coronary Artery Disease

   • I. Sudano
   • A.J. Flammer
   • F. Ruschitzka

   Contributions from International Congress 22 January 2013 Pages: 218 - 218

8. 5.11 ‘Raffaello Project’: Application of the ‘Disease and Care Management’ Approach in Cardiovascular Disease Prevention

   • A. Rappelli
   • M. Penco
   • A. Deales

   Contributions from International Congress 22 January 2013 Pages: 219 - 219

9. 5.12 Echocardiographic Study with Tissue Velocity and Strain Imaging Evaluation on the Effects of Exercise Training on Systo-Diastolic Ventricular Dysfunction In Patients With Hypertension

   • M. Leggio
   • L. Sgorbini
   • A.P. Jesi

   Contributions from International Congress 22 January 2013 Pages: 220 - 220

10. 5.13 Arterial Hypertension and Hyperhomocysteinaemia with TT Polymorphism of the C677T Gene for the 5-10-Methylenetetrahydrofolate Reductase: Risk Factors able to influence Clinical Management of the Patent Foramen Ovale?

    • A. Mazza
    • S. Zamboni
    • E. Casiglia

    Contributions from International Congress 22 January 2013 Pages: 221 - 221

    

11. 5.14 Obesity-Related Adjunctive Systo-Diastolic Ventricular Dysfunction in Patients with Hypertension: Echocardiographic Evaluation with Tissue Velocity and Strain Imaging

    • M. Leggio
    • L. Sgorbini
    • A.P. Jesi

    Contributions from International Congress 22 January 2013 Pages: 222 - 222

12. 5.15 Left Ventricular Patterns in a Population of a Hypertension Centre Echolab

    • D. Degli Esposti
    • A. Dormi
    • C. Borghi

    Contributions from International Congress 22 January 2013 Pages: 223 - 223

    

13. 5.16 Left Ventricular Geometry In Chronic Kidney Disease

    • E. Nardi
    • A. Palermo
    • G. Cerasola

    Contributions from International Congress 22 January 2013 Pages: 224 - 224

14. 5.17 Effects of Chronic Angiotensin II Administration on MicroRNA Expression in Rat Cardiovascular System

    • G. Castoldi
    • C. di Gioia
    • A. Stella

    Contributions from International Congress 22 January 2013 Pages: 225 - 225

    

15. 5.18 Cardiovascular and Metabolic Predictors of Progression to Overt Hypertension in a Population with Basal High-Normal Blood Pressure Levels: The Strong Heart Study

    • M. De Marco
    • M. Chinali
    • R.B. Devereux

    Contributions from International Congress 22 January 2013 Pages: 226 - 226

16. 5.19 Correlation Among Renal and Cardiac Function and Left Ventricular Geometries: The Strong Heart Study

    • M. De Marco
    • G. de Simone
    • R.B. Devereux

    Contributions from International Congress 22 January 2013 Pages: 227 - 227

17. 5.20 Metabolic Syndrome and Obstructive Sleep Apnoea In Patients with Visceral Obesity: Effect on Left Ventricular Remodelling

    • A.M. Maresca
    • A.M. Grandi
    • F. Avenco

    Contributions from International Congress 22 January 2013 Pages: 228 - 228

18. 5.21 Blood Pressure Levels, Left Ventricular Mass and Function are correlated with Left Atrial Volume in Mild to Moderate Hypertensive Patients

    • A. Milan
    • S. Delcolle
    • F. Veglio

    Contributions from International Congress 22 January 2013 Pages: 229 - 229

19. 5.22 Correlation Between Parameters of Non-invasive Haemodynamic Monitoring, Levels of Natriuretic Peptides and Echocardiographic Indexes of Diastolic Dysfunction in Chronic Systolic Heart Failure

    • G. Branzi
    • G. Malfatto
    • G. Parati

    Contributions from International Congress 22 January 2013 Pages: 230 - 230

20. 5.23 Determinants of Left Ventricular Mass (LVM) in White Obese Women

    • G. Salvetti
    • F. Santini
    • A. Salvetti

    Contributions from International Congress 22 January 2013 Pages: 231 - 231

    

21. 5.24 Obesity Increases the Effect of Sodium Intake on Left Ventricular Mass in Hypertensive Patients

    • R. Sarzani
    • F. Salvi
    • A. Rappelli

    Contributions from International Congress 22 January 2013 Pages: 232 - 232

22. 5.25 Green Tea Extracts Prevent Development of Cardiac Fibrosis in Angiotensin II-Dependent Hypertension by Blunting Oxidative Stress

    • M. Seccia
    • A.S. Belloni
    • G.P. Rossi

    Contributions from International Congress 22 January 2013 Pages: 233 - 233

23. 5.26 Left Ventricular Hypertrophy Prevalence by Different Left Ventricular Mass Indexes

    • D. Degli Esposti
    • A. Dormi
    • C. Borghi

    Contributions from International Congress 22 January 2013 Pages: 234 - 234

24. 5.27 Metabolic Syndrome and Multiple Organ Damage in Essential Hypertension

    • C. Cuspidi
    • C. Valerio
    • G. Mancia

    Contributions from International Congress 22 January 2013 Pages: 235 - 235

25. 6.1 Hypertension Associated with Obesity or Overweight: a Role for Aldosterone?

    • G.P. Rossi
    • A. Belfiore
    • F. Mantero

    Contributions from International Congress 22 January 2013 Pages: 236 - 236

26. 6.2 Comparison of Three Different Doses of ACTH Stimulation During Adrenal Vein Sampling (AVS) in the Work-Up of Primary Aldosteronism

    • M. Seccia
    • D. Miotto
    • G.P. Rossi

    Contributions from International Congress 22 January 2013 Pages: 237 - 237

27. 6.3 Pheochromocytoma: Clinical, Diagnostic and Genetic Aspects: Experience in a Single Centre

    • D. Cotesta
    • L. Petramala
    • C. Letizia

    Contributions from International Congress 22 January 2013 Pages: 238 - 238

28. 6.4 Cardiac Modifications in Patients with Primary Aldosteronism Before and After Specific Treatment

    • L. Petramala
    • D. Cotesta
    • G. Iacobellis

    Contributions from International Congress 22 January 2013 Pages: 239 - 239

29. 6.5 Silent Pheochromocytoma Presenting as Tako-Tsubo Syndrome during Anaesthesiological Stress

    • E. Malshi
    • C. Palombo
    • A. Salvetti

    Contributions from International Congress 22 January 2013 Pages: 240 - 240

30. 6.6 Polycystic Ovary Syndrome: Implications of Aldosterone and Progesterone Values in the Different Phases of the Cycle

    • S. Garelli
    • C. Fiore
    • D. Armanini

    Contributions from International Congress 22 January 2013 Pages: 241 - 241

31. 6.7 A Case of Left Ventricular Ballooning ‘Takotsubo Syndrome’ Associated with Pheochromocytoma

    • D. Cotesta
    • C. Letizia
    • C. Greco

    Contributions from International Congress 22 January 2013 Pages: 242 - 242

32. 6.8 Application of a New Chemiluminescent Method for Direct Renin Measurement to the Calculation of Aldosterone/Renin Ratio in Patients with Essential Hypertension

    • C. Lonati
    • A. Gritti
    • A. Morganti

    Contributions from International Congress 22 January 2013 Pages: 243 - 243

33. 6.9 Plasma Aldosterone and Albumin Urinary Excretion in Hypertension

    • G.L. Colussi
    • C. Catena
    • L. Sechi

    Contributions from International Congress 22 January 2013 Pages: 244 - 244

34. 6.10 Primary Hyperaldosteronism Treatment Reduces Left Ventricular Mass According to the Entity of Hormonal Production

    • C. Catena
    • G.L. Colussi
    • L. Sechi

    Contributions from International Congress 22 January 2013 Pages: 245 - 245

35. 6.11 Prevalence of Glycaemic Alteration in Hypertensive Subjects with Cardiac Hypertrophy

    • R. Pedrazzoli
    • S. Onolfo
    • E. Bartoli

    Contributions from International Congress 22 January 2013 Pages: 246 - 246

36. 6.12 Long-Term Effects of Pharmacological and Surgical Treatment on Cardiovascular Parameters in Patients with Primary Aldosteronism

    • G. Bernini
    • R. Pisano
    • A. Salvetti

    Contributions from International Congress 22 January 2013 Pages: 247 - 247

37. 6.13 Correlation Between TSH and Blood Pressure and Thyroid Diseases Prevalence in a Cohort of Patients with Primary Aldosteronism

    • F. Turchi
    • V. Ronconi
    • G. Giacchetti

    Contributions from International Congress 22 January 2013 Pages: 248 - 248

38. 6.14 Activation of the Renin-Angiotensin-Aldosterone System during Drospirenone Administration for Contraception

    • E. Porteri
    • S. Paiardi
    • E. Agabiti Rosei

    Contributions from International Congress 22 January 2013 Pages: 249 - 249

39. 6.15 Roles of Clinical Criteria, CT Scan and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes

    • P. Mulatero
    • C. Bertello
    • F. Veglio

    Contributions from International Congress 22 January 2013 Pages: 250 - 250

40. 6.16 Rapid Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism

    • P. Mulatero
    • C. Bertello
    • F. Veglio

    Contributions from International Congress 22 January 2013 Pages: 251 - 251

41. 6.17 Late Identification of a Tumour of the Juxta-Glomerular Apparatus (TJGA) in a Case of Longstanding Severe High-Renin Hypertension and Hypokalaemia

    • G. Regolisti
    • A. Cabassi
    • E. Fiaccadori

    Contributions from International Congress 22 January 2013 Pages: 252 - 252

    

42. 7.1 Left Ventricular Strain in Subjects Affected from Arterial Hypertension

    • A. Pierini
    • F. Magrini
    • B. Abdel Ghani

    Contributions from International Congress 22 January 2013 Pages: 253 - 253

43. 7.2 Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients during Anti-Hypertensive Treatment: the Life Study

    • M. Chinali
    • G. de Simone
    • R.B. Devereux

    Contributions from International Congress 22 January 2013 Pages: 254 - 254

44. 7.3 Association of Carotid Artery Stiffness Assessed with E-Tracking and Diastolic Dysfunction Assessed with Tissue Doppler Imaging Inpatients with Masked Hypertension

    • F. Natale
    • C. Siniscalchi
    • R. Calabrò

    Contributions from International Congress 22 January 2013 Pages: 255 - 255

45. 7.4 Early Cardiac Damage in High Cardiovascular Risk Patients

    • A.C.M Capra
    • M. Galderisi
    • G. Mancia

    Contributions from International Congress 22 January 2013 Pages: 256 - 256

46. 8.1 Factors Associated With Renal Dysfunction In Arterial Hypertension: The REDHY Study

    • G. Cerasola
    • G. Mule−
    • M. Guarneri

    Contributions from International Congress 22 January 2013 Pages: 257 - 257

47. 8.2 Glomerular Filtration Rate by Creatinine and Cystatin C Measurements in Essential Hypertensive Patients

    • S. Cottone
    • M. Guarneri
    • R. Arsena

    Contributions from International Congress 22 January 2013 Pages: 258 - 258

48. 8.3 Which is the Best Cut-Off for the Definition of Microalbuminuria Using a Timed Urine Collection? Results in an Adult Sample of Male Population

    • A. Barbato
    • F. Galletti
    • P. Strazzullo

    Contributions from International Congress 22 January 2013 Pages: 259 - 259

    

49. 8.4 Circulating Levels of E-Selectin are Inversely Related to Left Ventricular Wall Thickness in Patients on Regular Dialysis

    • B. Stancanelli
    • A. Cataliotti
    • L.S. Malatino

    Contributions from International Congress 22 January 2013 Pages: 260 - 260

50. 9.1 Pro-Arrhythmogenic Role of Sympathetic Activation and Baroreflex Dysfunction in Human Obesity

    • F. Arenare
    • G. Seravalle
    • G. Mancia

    Contributions from International Congress 22 January 2013 Pages: 261 - 261